Literature DB >> 22714402

[Life-threatening fentanyl and propofol addiction: interview with a survivor].

C Maier1, J Leclerc-Springer.   

Abstract

Anesthesiologists have a well-known increased risk of substance abuse including the intravenous administration of opioids and propofol. However, katamnestic reports from the point of view of propofol-addicted anesthesiologists themselves are missing which would aid a better understanding of the dynamics and progress of addiction. This article presents an interview with a formerly addicted female anesthesiologist who after long-term abuse with oral tilidine combined with naloxone switched to intravenous administration of fentanyl and later on propofol. Several life-threatening incidents occurred but after some severe setbacks occupational rehabilitation outside the field of anesthesiology was successful following inpatient treatment. This case shows exemplarily in accordance with the current literature that warning signs in addicted physicians are often ignored by colleagues and supervisors and rehabilitation is possible under professional therapy and continuous surveillance. Additionally, this case emphasizes the necessity of controlling the distribution of propofol to reduce the life-threatening professional risk to anesthesiologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22714402     DOI: 10.1007/s00101-012-2036-y

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  42 in total

1.  [A case report on a 9-day-long abuse of propofol].

Authors:  H Gündel; H Kuhs
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  1992-05       Impact factor: 0.698

2.  Death related to a recreational abuse of propofol at therapeutic dose range.

Authors:  A Roussin; M Mirepoix; G Lassabe; V Dumestre-Toulet; V Gardette; J-L Montastruc; M Lapeyre-Mestre
Journal:  Br J Anaesth       Date:  2006-08       Impact factor: 9.166

Review 3.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 4.  Doctors' health and fitness to practise: treating addicted doctors.

Authors:  E Jane Marshall
Journal:  Occup Med (Lond)       Date:  2008-08       Impact factor: 1.611

5.  A survey of inhalational anaesthetic abuse in anaesthesia training programmes.

Authors:  J E Wilson; N Kiselanova; Q Stevens; R Lutz; T Mandler; Z V Tran; P E Wischmeyer
Journal:  Anaesthesia       Date:  2008-06       Impact factor: 6.955

6.  Propofol dependency.

Authors:  M Soyka; C G Sch utz
Journal:  Addiction       Date:  1997-10       Impact factor: 6.526

Review 7.  [Assessment of the addictive risk of propofol].

Authors:  U Bonnet
Journal:  Fortschr Neurol Psychiatr       Date:  2011-08-01       Impact factor: 0.752

8.  [Prevalence and risk factors for substance abuse and dependence among anaesthetists: a national survey].

Authors:  L Beaujouan; S Czernichow; J-L Pourriat; F Bonnet
Journal:  Ann Fr Anesth Reanim       Date:  2005-04-12

9.  Tilidine abuse and dependence.

Authors:  A Trojan; H W Beil
Journal:  Drug Alcohol Depend       Date:  1978-11       Impact factor: 4.492

Review 10.  Dopamine signals for reward value and risk: basic and recent data.

Authors:  Wolfram Schultz
Journal:  Behav Brain Funct       Date:  2010-04-23       Impact factor: 3.759

View more
  3 in total

Review 1.  [Misuse of opioid analgesics. An internet analysis].

Authors:  R Krüger; W Meißner; A Zimmer
Journal:  Schmerz       Date:  2014-10       Impact factor: 1.107

2.  [Deaths from propofol abuse : Survey of institutes of forensic medicine in Germany, Austria and Switzerland].

Authors:  C Maier; J Iwunna; M Tsokos; F Mußhoff
Journal:  Anaesthesist       Date:  2017-01-13       Impact factor: 1.041

3.  Propofol sedation during gastrointestinal endoscopy arouses euphoria in a large subset of patients.

Authors:  Thorsten Brechmann; Christoph Maier; Miriam Kaisler; Jan Vollert; Wolff Schmiegel; Svetlana Pak; Norbert Scherbaum; Fred Rist; Andrea Riphaus
Journal:  United European Gastroenterol J       Date:  2017-10-04       Impact factor: 4.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.